1. Home
  2. AIRI vs RGNT Comparison

AIRI vs RGNT Comparison

Compare AIRI & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Air Industries Group

AIRI

Air Industries Group

N/A

Current Price

$2.65

Market Cap

12.3M

Sector

Industrials

ML Signal

N/A

Logo Regentis Biomaterials Ltd. Ordinary Shares

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$1.24

Market Cap

14.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIRI
RGNT
Founded
1979
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.3M
14.3M
IPO Year
2013
2022

Fundamental Metrics

Financial Performance
Metric
AIRI
RGNT
Price
$2.65
$1.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
34.4K
★ 42.7K
Earning Date
11-09-2026
09-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 24.39
N/A
EPS
N/A
★ N/A
Revenue
★ $47,921,000.00
N/A
Revenue This Year
$4.34
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.30
$1.16
52 Week High
$3.95
$15.50

Technical Indicators

Market Signals
Indicator
AIRI
RGNT
Relative Strength Index (RSI) 48.14 37.75
Support Level $2.50 $1.23
Resistance Level $2.75 $2.52
Average True Range (ATR) 0.23 0.15
MACD 0.02 0.01
Stochastic Oscillator 50.53 14.30

Price Performance

Historical Comparison
AIRI
RGNT

About AIRI Air Industries Group

Air Industries Group is an aerospace and defense company. Its manufacturers of precision components and assemblies for large aerospace and defense prime contractors. The company products include landing gears, flight controls, engine mounts and components for aircraft jet engines, ground turbines and other complex machines. The ultimate end-user of products is the U.S. Government, international governments, and commercial global airlines.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: